News

The Board of Directors of GrafTech International Ltd. (NYSE:EAF) (the “Company”) declared a quarterly cash dividend of $0.01 per share to stockholders of record as of the close of business on

Archaea Energy Inc. (“Archaea,” “the Company,” or “we”) (NYSE: LFG), one of the largest producers of renewable natural gas (“RNG”) in the U.S., today announced financial and operating results for

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system

US Foods Holding Corp. (NYSE: USFD) announced today that Dirk Locascio, chief financial officer, will participate in a fireside chat at the Barclays Eat, Sleep, Play Conference in New York City on

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries

Corporate Office Properties Trust (NYSE: OFC) (“COPT” or the “Company”) announced today that its Board of Trustees declared a regular quarterly dividend of $0.275 per common share for the fourth

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending September 30, 2022 and provided

The Board of Directors of Xylem Inc. (NYSE: XYL), has declared a fourth quarter dividend of $0.30 per share payable on December 20, 2022 to shareholders of record as of November 22, 2022.

About

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported financial and

Intelligent power management company Eaton (NYSE:ETN) is excited to announce that it has been named a Mansfield 2.0 Certified Legal Department (MRLD) and achieved the MRLD Certification Plus

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that

IMV Inc. (Nasdaq: IMV; TSX: IMV) (“IMV” or the “Company”), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX^® platform to treat

Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis

AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter

(NASDAQ: RDFN) — Home-sale prices rose 3.2% year over year during the four-week period ending November 6, the smallest increase since July 2020, according to a new report from Redfin (redfin.com)

Insight Enterprises (NASDAQ:NSIT), a Fortune 500 solutions integrator helping organizations accelerate their digital journey, announced today that Emma de Sousa is stepping down from her current

Regulatory News:

Teleperformance (Paris:TEP), the global leader in outsourced customer and citizen experience management and related digital services, has requested Euronext Paris to resume the

ServiceNow (NYSE: NOW) today announced that it will attend and have executives present at three upcoming investor conferences. These include:

• 
  ServiceNow Chairman and Chief Executive Officer Bill
  

Enterprises and service providers are facing a talent crunch that requires them to double down on employee engagement programs to attract and retain people with critical skill sets, says an expert